101 related articles for article (PubMed ID: 12212630)
1. Age-related changes in the D-aspartic acid content of the cranial bones in senescence-accelerated mice (SAM).
Ohtani S; Yamamoto T; Sashima M; Satoh M
Growth Dev Aging; 2002; 66(1):35-41. PubMed ID: 12212630
[TBL] [Abstract][Full Text] [Related]
2. Age-related changes in the D-aspartic acid content of the teeth of the senescence-accelerated mouse.
Ohtani S; Yamamoto T; Sugimoto H; Sashima M; Satoh M
Arch Oral Biol; 2000 Jan; 45(1):13-8. PubMed ID: 10669088
[TBL] [Abstract][Full Text] [Related]
3. Age-related changes of the cementogenesis in the senescence-accelerated mouse (SAM).
Sashima M; Satoh M
J Periodontal Res; 1996 Oct; 31(7):470-6. PubMed ID: 8915949
[TBL] [Abstract][Full Text] [Related]
4. Age-related changes of anti-elastin antibodies in senescence-accelerated mice.
Atanasova M; Konova E; Georgieva M; Dimitrova A; Coquand-Gandit M; Faury G; Baydanoff S
Gerontology; 2010; 56(3):310-8. PubMed ID: 19752527
[TBL] [Abstract][Full Text] [Related]
5. Favorable effects of a prolonged treatment with melatonin on the level of oxidative damage and neurodegeneration in senescence-accelerated mice.
Caballero B; Vega-Naredo I; Sierra V; Huidobro-Fernández C; Soria-Valles C; De Gonzalo-Calvo D; Tolivia D; Gutierrez-Cuesta J; Pallas M; Camins A; Rodríguez-Colunga MJ; Coto-Montes A
J Pineal Res; 2008 Oct; 45(3):302-11. PubMed ID: 18410310
[TBL] [Abstract][Full Text] [Related]
6. Age-related changes in blood pressure in the senescence-accelerated mouse (SAM): aged SAMP1 mice manifest hypertensive vascular disease.
Han J; Hosokawa M; Umezawa M; Yagi H; Matsushita T; Higuchi K; Takeda T
Lab Anim Sci; 1998 Jun; 48(3):256-63. PubMed ID: 10090025
[TBL] [Abstract][Full Text] [Related]
7. 6R-L-erythro-5,6,7,8-tetrahydrobiopterin is involved in brain vulnerability of senescence-accelerated mouse during the processes of aging.
Yoshimoto K; Yoshida T; Hirano A; Ueda S
Growth Dev Aging; 1997; 61(3-4):157-65. PubMed ID: 9546106
[TBL] [Abstract][Full Text] [Related]
8. NMR-based metabonomic investigations into the metabolic profile of the senescence-accelerated mouse.
Jiang N; Yan X; Zhou W; Zhang Q; Chen H; Zhang Y; Zhang X
J Proteome Res; 2008 Sep; 7(9):3678-86. PubMed ID: 18656976
[TBL] [Abstract][Full Text] [Related]
9. Ameliorative effects of lotus seedpod proanthocyanidins on cognitive deficits and oxidative damage in senescence-accelerated mice.
Gong Y; Liu L; Xie B; Liao Y; Yang E; Sun Z
Behav Brain Res; 2008 Dec; 194(1):100-7. PubMed ID: 18652848
[TBL] [Abstract][Full Text] [Related]
10. Age dependence of motor activity and sensitivity to dopamine receptor 1 agonist, SKF82958, of inbred AKR/J, BALB/c, C57BL/6J, SAMR1, and SAMP6 strains.
Niimi K; Takahashi E; Itakura C
Brain Res; 2009 Jan; 1250():175-82. PubMed ID: 19007759
[TBL] [Abstract][Full Text] [Related]
11. Age-related difference in nociceptive behavior between SAMP6 and SAMR1 strains.
Niimi K; Takahashi E; Itakura C
Neurosci Lett; 2008 Oct; 444(1):60-3. PubMed ID: 18703115
[TBL] [Abstract][Full Text] [Related]
12. Age-dependent changes in the racemisation ratio of aspartic acid in human alveolar bone.
Ohtani S; Yamamoto T; Abe I; Kinoshita Y
Arch Oral Biol; 2007 Mar; 52(3):233-6. PubMed ID: 17097046
[TBL] [Abstract][Full Text] [Related]
13. Cerebral plasmalogens and aldehydes in senescence-accelerated mice P8 and R1: a comparison between weaned, adult and aged mice.
André A; Chanséaume E; Dumusois C; Cabaret S; Berdeaux O; Chardigny JM
Brain Res; 2006 Apr; 1085(1):28-32. PubMed ID: 16581039
[TBL] [Abstract][Full Text] [Related]
14. Long bones from the senescence accelerated mouse SAMP6 have increased size but reduced whole-bone strength and resistance to fracture.
Silva MJ; Brodt MD; Ettner SL
J Bone Miner Res; 2002 Sep; 17(9):1597-603. PubMed ID: 12211429
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of aspartic acid racemization ratios in the human femur for age estimation.
Ohtani S; Matsushima Y; Kobayashi Y; Kishi K
J Forensic Sci; 1998 Sep; 43(5):949-53. PubMed ID: 9729809
[TBL] [Abstract][Full Text] [Related]
16. Effect of aging on species-typical behaviors in senescence-accelerated mouse.
Chen GH; Wang YJ; Wang XM; Zhou JN; Liu RY
Physiol Behav; 2005 Aug; 85(5):536-45. PubMed ID: 16005914
[TBL] [Abstract][Full Text] [Related]
17. Morphological analysis of skin in senescence-accelerated mouse P10.
Luo Y; Toyoda M; Nakamura M; Morohashi M
Med Electron Microsc; 2002 Mar; 35(1):31-45. PubMed ID: 12111405
[TBL] [Abstract][Full Text] [Related]
18. Consistency of low bone density across bone sites in SAMP6 laboratory mice.
Kasai S; Shimizu M; Matsumura T; Okudaira S; Matsushita M; Tsuboyama T; Nakamura T; Hosokawa M
J Bone Miner Metab; 2004; 22(3):207-14. PubMed ID: 15108062
[TBL] [Abstract][Full Text] [Related]
19. Western diet consumption promotes vascular remodeling in non-senescent mice consistent with accelerated senescence, but does not modify vascular morphology in senescent ones.
Dantas AP; Onetti Y; Oliveira MA; Carvalho MH; Heras M; Vila E; Jiménez-Altayó F
Exp Gerontol; 2014 Jul; 55():1-11. PubMed ID: 24607550
[TBL] [Abstract][Full Text] [Related]
20. Melatonin administration prevents cardiac and diaphragmatic mitochondrial oxidative damage in senescence-accelerated mice.
Rodriguez MI; Escames G; López LC; García JA; Ortiz F; López A; Acuña-Castroviejo D
J Endocrinol; 2007 Sep; 194(3):637-43. PubMed ID: 17761903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
